Dermapharm Aktie
WKN DE: A2GS5D / ISIN: DE000A2GS5D8
07.11.2023 14:56:18
|
EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
EQS Preliminary announcement financial reports: Dermapharm Holding SE
/ Preliminary announcement on the disclosure of financial statements
Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:
Report Type: Quarterly/ Interim statement within the 2nd half-year Language: German Date of disclosure: November 15, 2023 Address: https://ir.dermapharm.de/#Finanzberichte Language: English Date of disclosure: November 15, 2023 Address: https://ir.dermapharm.de/index-EN.php#Finanzberichte
07.11.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Dermapharm Holding SE |
Lil-Dagover-Ring 7 | |
82031 Grünwald | |
Germany | |
Internet: | ir.dermapharm.de |
End of News | EQS News Service |
|
1767287 07.11.2023 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Dermapharm Holding SEmehr Nachrichten
Analysen zu Dermapharm Holding SEmehr Analysen
14.03.25 | Dermapharm Buy | Jefferies & Company Inc. | |
05.12.24 | Dermapharm Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
28.11.24 | Dermapharm Buy | Jefferies & Company Inc. | |
15.11.24 | Dermapharm Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
14.11.24 | Dermapharm Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Dermapharm Holding SE | 38,40 | -4,95% |
|